07:00 , Jun 14, 2010 |  BC Week In Review  |  Clinical News

Breast tomosynthesis: Pivotal trial started

In April, researchers began a U.S. pivotal trial to compare Hologic’s breast tomosynthesis to conventional 2-D digital mammography. Breast tomosynthesis is commercially available in Europe and Canada. Hologic Inc. (NASDAQ:HOLX), Bedford, Mass.   Product: Breast...